Category Archives: Stem Cell Research

Evan Snyder - Stem Cell Research : The Teenage Years thesciencenetwork.org Evan Snyder surveys the history of stem cell research into its current "teenage" years, in which the answers are less easy and clean cut. Scientists understand much about stem cells functioning as the building blocks of the body and maintaining balance, but there is a lot yet to discover including mechanisms of diseases in order to target stem cell therapies. Dr. Synder also describes his path to science and medicine, driven at a young age to take care of kids after working a center for disadvantaged and disabled children. Evan Snyder is regarded as one of the fathers of the stem cell field, having identified over two decades ago that cells that came to be called stem cells were a source of neural plasticity. He was the first to demonstrate that non-hematopoietic stem cells could mediate cell and gene replacement, home to injury, and perform protective, trophic, pro-regenerative, and anti-inflammatory actions. He was the first to isolate human neural stem cells. In 2003, after 23 years at Harvard, Dr. Snyder was recruited to Sanford Burnham Medical Research Institute as professor and director of the Stem Cells and Regenerative Biology … Continue reading →

Dr. Alex Meissner -- Advances in Stem Cell Research Learn more at http://www.invitrogen.com Dr. Alex Meissner, Assistant Professor at the Department of Stem Cell and Regenerative Biology at Harvard University, discusses how next generation sequencing has revolutionized the way we look at stem cells and perform stem cell research. Dr. Meissner talks about the challenges of interpreting genome wide data to provide stem cells with the right cues for efficient proliferation and differentiation and how the resulting cell models can be used to improve compound screening and cell therapy research applications.From:LifeTechnologiesCorpViews:0 1ratingsTime:02:56More inEducation The rest is here: Dr. Alex Meissner -- Advances in Stem Cell Research - Video … Continue reading →

Stem cell research: Teeth could hold key to future health The dental pulp will be collected, frozen and stored so the youngster can take advantage of future advances in medical science.Her father says the stem cells could potentially be used in the treatment of diseases, conditions or injuries that may befall the child down the line.From:pressassociationViews:6 0ratingsTime:01:43More inNews Politics Continue reading here: Stem cell research: Teeth could hold key to future health - Video … Continue reading →

Donna Dickenson introduces Bioethics All That Matters author Donna Dickenson introduces the topic covered in her book, Bioethics. Bioethics: All That Matters shows how new departments in biotechnology - like genetics, stem cell research and artificial reproduction - arouse both our greatest hopes and our greatest fears.From:AllThatMattersBooksViews:0 0ratingsTime:01:52More inEducation Go here to read the rest: Donna Dickenson introduces Bioethics - Video … Continue reading →

T-shirts: Claim Your I am 47 percent T-shirts Mr. Romney claims to have experience reaching across the aisle. Maybe he did do some reaching, but not much of it went toward the Democrats. In his first two years of office, he vetoed legislation at more than twice the rate of Republican predecessor Governor Weld. Governor Romney had a record 800 vetoes (most of which were overturned, sometimes unanimously). One example is when the legislature provided a budget amendment to stop contracting with companies that outsource state work to other countries. Governor Romney vetoed the provision. This meant that he supported outsourcing jobs at the expense of US workers. He also started a huge campaign to unseat Democratic legislators, but failed and ended up with even fewer Republican seats than before he took office. Governor Romney correctly claims that Massachusetts rose to #1 in education mdash;but it was based on former Governor Weld's education reform plan. Governor Romney moved in the opposite direction--he vetoed bills that would have strengthened preschool education. However, the issue is not so much how he voted, but that Mr. Romney won the governorship by presenting himself in one way, as a social and fiscal moderate … Continue reading →

Public release date: 1-Nov-2012 [ | E-mail | Share ] Contact: Anita Srikameswaran srikamav@upmc.edu 412-578-9193 University of Pittsburgh Schools of the Health Sciences PITTSBURGH, Nov. 1, 2012 An injection of banked sperm-producing stem cells can restore fertility to male primates who become sterile due to cancer drug side effects, according to researchers at the University of Pittsburgh School of Medicine and Magee-Womens Research Institute. In their animal study, which was published today in Cell Stem Cell, previously frozen stem cells restored production of sperm that successfully fertilized eggs to produce early embryos. Some cancer drugs work by destroying rapidly dividing cells. As it is not possible to discriminate between cancer cells and other rapidly dividing cells in the body, the precursor cells involved in making sperm can be inadvertently wiped out leaving the patient infertile, said senior investigator Kyle Orwig, Ph.D., associate professor, Department of Obstetrics, Gynecology and Reproductive Medicine, Pitt School of Medicine, and an investigator at Magee-Womens Research Institute. "Men can bank sperm before they have cancer treatment if they hope to have biological children later in their lives," he said. "But that is not an option for young boys who haven't gone through puberty, can't provide a … Continue reading →

KUALA LUMPUR: There are no plans to introduce a stem cell Act at the moment, said Health Minister Datuk Seri Liow Tiong Lai. He said the ministry's four guidelines on stem cell research sufficiently served as standards to which practitioners and scientists involved in stem cell research and therapy should adhere to, ensured patients were out of harm's way. The guidelines would provide a framework for researchers, clinicians and companies involved in research, clinical trials and manufacture of stem cells, he noted. "There is no stem cell Act in this country. But the guidelines alone are sufficient to provide the grounds and ethical environment to carry out their work," Liow told reporters after launching the 1st National Stem Cell Congress here Monday. The four guidelines are National Standards For Haemopoietic Stem Cell Therapy, National Standards For Cord Blood Banking and Transplantation, National Standards For Stem Cell Transplantation and Guidelines On Stem Cell Research and Therapy. "Before we came up with the guidelines, we formed a committee to discuss the details of the research. The committee also included Jakim and religious officials for their views," Liow said. He said the use of cell-based therapies should be done strictly under clinical trials. … Continue reading →

Public release date: 1-Nov-2012 [ | E-mail | Share ] Contact: Rachel Mosey rmosey@mcw.edu Medical College of Wisconsin The Medical College of Wisconsin (MCW) Center for International Blood and Marrow Transplant Research (CIBMTR) successfully competed for, and was awarded, renewal of the Stem Cell Therapeutics Outcomes Database contract with the U.S. Health Resources and Services Administration (HRSA). The CIBMTR administers the database as a key component of the national hematopoietic cell transplantation program. Hematopoietic stem cells are the cells responsible for continual regeneration of circulating blood cells throughout life; they are not embryonic stem cells. The HRSA first awarded the contract to CIBMTR in 2006 to develop and maintain the national Stem Cell Therapeutic Outcomes Database (SCTOD), which is a standardized outcomes registry of allogeneic (related and unrelated donor cells) marrow and cord blood transplants performed in the United States. Funding for the first year of this new contract is $3.8 million, with an additional four years of negotiable funding. The outcomes registry of the CIBMTR currently contains the status of 330,000 transplant recipients, as well as critical information to continually evaluate the operations of the national transplant program. All U.S. transplant centers that perform allogeneic marrow and cord blood … Continue reading →

A Cambridge University technology team that developed a way to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors. DefiniGEN is based on the research of Dr Ludovic Vallier, Dr Tamir Rashid and global stem cell guru Professor Roger Pedersen of the Anne McLaren Laboratory of Regenerative Medicine. DefiniGEN is based in Cambridge and has been funded by a group led by Cambridge Enterprise, the Universitys commercialisation arm, along with members of Cambridge Angels and Cambridge Capital Group. Prof Pedersen is one of the coveted brains of stem cell research. He moved to Cambridge to escape a puritan US approach to stem cell research and has resisted attempts to woo him back across the Atlantic. The potential therapeutic applications of stem cells such as regenerating damaged tissues or organs have generated a great deal of interest over the past decade. While these types of applications are exciting, it is a long journey from lab to clinic. The most immediate impact of stem cells on human health will most likely come from their use in the development of new drugs. The ability to generate stem cells … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ks4gfv/hematopoietic) has announced the addition of Global Markets Direct's new report "Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012" to their offering. Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012', provides an overview of the Hematopoietic Stem Cell Transplantation therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation. Scope - A snapshot of the global therapeutic scenario for Hematopoietic Stem Cell Transplantation. - A review of the Hematopoietic Stem Cell Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Hematopoietic Stem Cell Transplantation pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. Read more from the original source: Research and Markets: Hematopoietic Stem Cell Transplantation - Pipeline … Continue reading →